✦ LIBER ✦

A Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Oxybutynin Vaginal Ring for Alleviation of Overactive Bladder Symptoms in Women

✍ Scribed by Gittelman, Marc; Weiss, Herman; Seidman, Larry

Book ID: 122269102
Publisher: Lippincott Williams and Wilkins
Year: 2014
Tongue: English
Weight: 418 KB
Volume: 191
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.11.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFICACY AND SAFETY OF OXYBUTYNIN CHLORI

EFFICACY AND SAFETY OF OXYBUTYNIN CHLORIDE TOPICAL GEL IN WOMEN WITH OVERACTIVE BLADDER: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY

✍ Dmochowski, Roger R; Staskin, David R; Sand, Peter K; MacDiarmid, Scott A; Caram 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

Efficacy and Safety of Oxybutynin Chlori

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Multicenter Study

✍ Rovner, E.S. 📂 Article 📅 2010 🏛 Elsevier Science ⚖ 46 KB

Efficacy and Safety of Oxybutynin Chlori

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

✍ Staskin, David R.; Dmochowski, Roger R.; Sand, Peter K.; MacDiarmid, Scott A.; C 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 259 KB

565 PHASE 3 EFFICACY AND SAFETY OF ONCE-

565 PHASE 3 EFFICACY AND SAFETY OF ONCE-MONTHLY OXYBUTYNIN VAGINAL RING DELIVERING 4 MG/DAY OR 6 MG/DAY VS PLACEBO RING IN WOMEN WITH URGE INCONTINENCE, FREQUENCY, AND URGENCY SYMPTOMS OF OVERACTIVE BLADDER

✍ Swierzewski, Mark; Seidman, Larry; Dasen, Sue; Weiss, Herman 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 155 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome

✍ Dudley Robinson; Linda Cardozo; Gerben Terpstra; John Bolodeoku; the Tamsulosin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Randomized Double-blind, Active-controll

Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder

✍ Christopher R. Chapple; Steven A. Kaplan; David Mitcheson; Jiri Klecka; Jana Cum 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 508 KB